(2-benzylpiperidin-1-yl)(4-(4-bromophenyl)-1H-1,2,3-triazol-1-yl)methanone | 1402612-54-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (2-benzylpiperidin-1-yl)(4-(4-bromophenyl)-1H-1,2,3-triazol-1-yl)methanone
• 英文别名: Methanone, [4-(4-broMophenyl)-1H-1,2,3-triazol-1-yl][2-(phenylMethyl)-1-piperidinyl]-；(2-benzylpiperidin-1-yl)-[4-(4-bromophenyl)triazol-1-yl]methanone
• CAS: 1402612-54-7
• 化学式: C₂₁H₂₁BrN₄O
• 分子量: 425.328
• InChiKey: CJRUAEPWPPDNAV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  51
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (2-benzylpiperidin-1-yl)(4-(4-bromophenyl)-1H-1,2,3-triazol-1-yl)methanone 、 3-羟甲基苯硼酸 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 2.0h， 以44%的产率得到(2-benzylpiperidin-1-yl)(4-(3'-(hydroxymethyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone
  参考文献：
  名称：

  Development and Optimization of Piperidyl-1,2,3-Triazole Ureas as Selective Chemical Probes of Endocannabinoid Biosynthesis

  摘要：

  We have previously shown that 1,2,3-triazole ureas (1,2,3-TUs) act as versatile class of irreversible serine hydrolase inhibitors that can be tuned to create selective probes for diverse members of this large enzyme class, including diacylglycerol lipase-beta (DAGL beta), a principal biosynthetic enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG). Here, we provide a detailed account of the discovery, synthesis, and structure-activity relationship (SAR) of (2-substituted)-piperidyl-1,2,3-TUs that selectively inactivate DAGL beta in living systems. Key to success was the use of activity-based protein profiling (ABPP) with broad-spectrum and tailored activity-based probes to guide our medicinal chemistry efforts. We also describe an expanded repertoire of DAGL-tailored activity-based probes that includes biotinylated and alkyne agents for enzyme enrichment coupled with mass spectrometry-based proteomics and assessment of proteome-wide selectivity. Our findings highlight the broad utility of 1,2,3-TUs for serine hydrolase inhibitor development and their application to create selective probes of endocannabinoid biosynthetic pathways.

  DOI：

  10.1021/jm400898x
• 作为产物：
  描述：

  2-苄基哌啶 、 三光气 、 5-(4-溴苯基)-1H-1,2,3-噻唑 在 N,N-二异丙基乙胺 、 4-二甲氨基吡啶 作用下， 以 四氢呋喃 为溶剂， 反应 2.5h， 以42%的产率得到(2-benzylpiperidin-1-yl)(4-(4-bromophenyl)-1H-1,2,3-triazol-1-yl)methanone
  参考文献：
  名称：

  [FR] INHIBITEURS DES SÉRINE HYDROLASES DE TYPE N1- ET N2-CARBAMOYL-1,2,3-TRIAZOLE ET MÉTHODES ASSOCIÉES

  摘要：

  本发明提供了多种丝氨酸水解酶的抑制剂。本发明的抑制剂是N1-和N2-羰胺基-1,2,3-三唑化合物，如式（I）所示：（式（I）），其中N1、N2和N3分别为三唑环的1、2和3位置的氮原子，式（I）中的R4、R5、R6和R7如本文所述。还描述了抑制丝氨酸水解酶酶和制备羰胺基-1,2,3-三唑化合物的方法。

  公开号：

  WO2012138877A1

文献信息

• [EN] TRIAZOLE DAGL(α) INHIBITORS<br/>[FR] INHIBITEURS À TRIAZOLE DE DAGL(Α)
  申请人：SCRIPPS RESEARCH INST

  公开号：WO2017096315A1

  公开（公告）日：2017-06-08

  Provided herein are triazole compounds and pharmaceutical compositions comprising said compounds useful as modulators of DAGL(α) and DAGL(β). In some embodiments, the compounds described herein are selective DAGL(α) inhibitors. Furthermore, the subject compounds and compositions are useful for the treatment of neurodegenerative or neuroinflammatory disease.

  本文提供了三唑化合物和含有这些化合物的药物组合物，用作DAGL(α)和DAGL(β)的调节剂。在某些实施例中，本文描述的化合物是选择性的DAGL(α)抑制剂。此外，所述化合物和组合物对于治疗神经退行性或神经炎症性疾病是有用的。
• Discovery and Optimization of Piperidyl-1,2,3-Triazole Ureas as Potent, Selective, and in Vivo-Active Inhibitors of α/β-Hydrolase Domain Containing 6 (ABHD6)
  作者：Ku-Lung Hsu、Katsunori Tsuboi、Jae Won Chang、Landon R. Whitby、Anna E. Speers、Holly Pugh、Benjamin F. Cravatt

  DOI：10.1021/jm400899c

  日期：2013.11.14

  (2-substituted)-piperidyl-1,2,3-triazole urea inhibitors of ABHD6, including compounds KT182 and KT203, which show exceptional potency and selectivity in cells (<5 nM) and, at equivalent doses in mice (1 mg kg–1), act as systemic and peripherally restricted ABHD6 inhibitors, respectively. We also describe an orally bioavailable ABHD6 inhibitor, KT185, that displays excellent selectivity against other brain and liver

  含有 6 的 α/β-水解酶结构域 (ABHD6) 是一种跨膜丝氨酸水解酶，可水解内源性大麻素 2-花生四烯酸甘油 (2-AG) 以调节神经系统中某些形式的大麻素受体依赖性信号传导。ABHD6 代谢活动和功能的全谱目前尚不清楚，并且将受益于选择性的体内活性抑制剂。在这里，我们报告了一系列先进的 ABHD6 不可逆（2-取代）-哌啶基-1,2,3-三唑脲抑制剂的开发和表征，包括化合物 KT182 和 KT203，它们在细胞中显示出非凡的效力和选择性（< 5 nM) 和，在小鼠中的等效剂量 (1 mg kg –1)，分别作为全身性和外周限制性 ABHD6 抑制剂。我们还描述了一种口服生物可利用的 ABHD6 抑制剂 KT185，它在体内对其他脑和肝脏丝氨酸水解酶具有出色的选择性。因此，我们描述了几种用于 ABHD6 生物学研究的化学探针，包括脑渗透性和外周限制性抑制剂，它们应该证明在动物模型中询问
• N1- and N2-CARBAMOYL-1,2,3-TRIAZOLE SERINE HYDROLASE INHIBITORS AND METHODS
  申请人：Cravatt Benjamin

  公开号：US20140018318A1

  公开（公告）日：2014-01-16

  The present invention provides inhibitors of a wide variety of serine hydrolase enzymes. The inhibitors of the present invention are N1- and N2-carbamoyl-1,2,3-triazole compounds such as those of Formula (I): in which N1, N2, and N3 are the nitrogen atoms at positions 1, 2, and 3, respectively, of the triazole ring, and R 4 , R 5 , R 6 and R 7 in Formula (I) are as described herein. Methods of inhibiting serine hydrolase enzymes and methods of preparing carbamoyl-1,2,3-triazole compounds also are described.

  本发明提供了一种广泛的丝氨酸水解酶酶抑制剂。本发明的抑制剂是N1-和N2-氨基甲酰基-1,2,3-三唑化合物，例如公式（I）中的化合物：其中N1、N2和N3是三唑环的1、2和3位置的氮原子，公式（I）中的R4、R5、R6和R7如本文所述。还描述了抑制丝氨酸水解酶的方法和制备氨基甲酰基-1,2,3-三唑化合物的方法。
• US9108930B2
  申请人：——

  公开号：US9108930B2

  公开（公告）日：2015-08-18
• Development and Optimization of Piperidyl-1,2,3-Triazole Ureas as Selective Chemical Probes of Endocannabinoid Biosynthesis
  作者：Ku-Lung Hsu、Katsunori Tsuboi、Landon R. Whitby、Anna E. Speers、Holly Pugh、Jordon Inloes、Benjamin F. Cravatt

  DOI：10.1021/jm400898x

  日期：2013.11.14

  We have previously shown that 1,2,3-triazole ureas (1,2,3-TUs) act as versatile class of irreversible serine hydrolase inhibitors that can be tuned to create selective probes for diverse members of this large enzyme class, including diacylglycerol lipase-beta (DAGL beta), a principal biosynthetic enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG). Here, we provide a detailed account of the discovery, synthesis, and structure-activity relationship (SAR) of (2-substituted)-piperidyl-1,2,3-TUs that selectively inactivate DAGL beta in living systems. Key to success was the use of activity-based protein profiling (ABPP) with broad-spectrum and tailored activity-based probes to guide our medicinal chemistry efforts. We also describe an expanded repertoire of DAGL-tailored activity-based probes that includes biotinylated and alkyne agents for enzyme enrichment coupled with mass spectrometry-based proteomics and assessment of proteome-wide selectivity. Our findings highlight the broad utility of 1,2,3-TUs for serine hydrolase inhibitor development and their application to create selective probes of endocannabinoid biosynthetic pathways.